Marktgröße und Marktanteil von Therapeutika für das zentrale Nervensystem (ZNS) bis 2025 – 2031
Central Nervous System (CNS) Therapeutic Market Report Analysis
Central Nervous System (CNS) Therapeutic Market
-
CAGR (2025 - 2031)6.2% -
Market Size 2024
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Lilly
- Pfizer Inc.
- Otsuka Pharmaceutical Co., Ltd
- Biogen
- Merck Sharp and Dohme Corp
- AstraZeneca
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd
Regional Overview

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation

- Neurovaskuläre Erkrankungen
- Degenerative Erkrankungen
- Psychische Erkrankungen
- Trauma

- Analgetika
- Medikamente für das Nervensystem
- Anästhetika
- Medikamente gegen Parkinson
- Antiepileptika

- Krankenhausapotheken
- Einzelhandelsapotheken

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika